CXI Healthcare Technology Group Limited (KOSDAQ:900120)

South Korea · Delayed Price · Currency is KRW

2,920.00

-15.00 (-0.51%)

At close: Nov 13, 2026

KOSDAQ:900120 Financials Overview

Financials in millions KRW. Fiscal year is July - June.

Millions KRW. Fiscal year is Jul - Jun.

Revenue & Profits

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Jun '26 Jun 30, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022
Revenue	49,475	49,475	57,636	69,420	71,617	101,376
Revenue Growth	-14.16%	-14.16%	-16.97%	-3.07%	-29.35%	-3.08%
Gross Profit	11,764	11,764	17,316	29,876	28,213	28,358
Operating Income	2,986	2,986	9,700	18,653	7,136	6,292
Net Income	8,067	8,067	12,741	29,349	7,528	5,981
Earnings Per Share	30380.05	30380.05	53655.01	290000.36	15347.34	12000.00
EPS Growth	-43.38%	-43.38%	-81.50%	1789.58%	27.89%	4.75%

Cash & Debt

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Jun '26 Jun 30, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022
Cash & Investments	60,899	60,899	200,534	159,913	94,625	65,715
Total Debt	1,030	1,030	630.37	187.49	967.18	310.53
Net Cash (Debt)	59,869	59,869	199,903	159,726	93,657	65,404
Net Cash Growth	-70.05%	-70.05%	25.15%	70.54%	43.20%	162.33%
Net Cash Per Share	225452.43	225452.43	841856.98	1578269.49	190942.34	133341.30

Cash Flow & CapEx

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Jun '26 Jun 30, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022
Operating Cash Flow	38,724	38,724	40,236	43,666	31,597	35,984
Capital Expenditures	-231,829	-231,829	-55.92	-	-	-5.78
Free Cash Flow	-193,106	-193,106	40,180	43,666	31,597	35,979
Free Cash Flow Growth	-	-	-7.98%	38.19%	-12.18%	-

Margins

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Jun '26 Jun 30, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022
Gross Margin	23.78%	23.78%	30.04%	43.04%	39.39%	27.97%
Operating Margin	6.04%	6.04%	16.83%	26.87%	9.96%	6.21%
Pretax Margin	16.85%	16.85%	23.88%	42.27%	10.51%	5.90%
Profit Margin	16.31%	16.31%	22.11%	42.28%	10.51%	5.90%
FCF Margin	-390.31%	-390.31%	69.71%	62.90%	44.12%	35.49%

Valuation

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Nov '26 Nov 13, 2026	Jun '26 Jun 30, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022
PE Ratio	0.10	1.04	1.46	0.98	3.53	5.27
Forward PE	-	3.78	3.78	3.78	3.78	3.78
P/FCF Ratio	-	-	0.46	0.66	0.84	0.88
PS Ratio	0.20	0.17	0.32	0.42	0.37	0.31